C-UCM and Cerebral Oxygenation and Perfusion

NCT ID: NCT03748914

Last Updated: 2021-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-11-21

Study Completion Date

2019-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background

The transition to life after birth is a complex physiological process where the neonate has to establish sufficient ventilation and changes from intra-uterine circulation to extra-uterine circulation take place. During these processes the neonate has to provide the brain with adequate perfusion and oxygen delivery to maintain normal cerebral tissue oxygenation and activity. Instability of cerebral perfusion and oxygenation may be associated with brain damage in preterm infants. The concept of C-UCM may substitute the adverse effects of immediate cord clamping by supplying additional placental blood to the infant, which is mostly performed during caesarean section or in the critically ill neonate.

In this randomized controlled Pilot study the effects of cut-umbilical cord milking on cerebral oxygenation and perfusion measured via near-infrared spectroscopy (NIRS) and the effects on stroke volume (SV) and cardiac output (CO) also measured non-invasively in term and preterm infants are evaluated for the first 15 minutes after birth and compared to a control group.

Aim

The aim of the study is to analyse whether C-UCM in preterm and term infants results in an improvement of cerebral oxygenation and perfusion during immediate neonatal transition measured with NIRS.

Hypotheses

Infants undergoing C-UCM after birth compared to infants without C-UCM show differences in cerebral oxygenation and perfusion in the first 15 min after birth.

Hypothesis I: C-UCM and cerebral blood volume (CBV) In infants with C-UCM there is more CBV decrease immediately after birth, compared to infants without C-UCM, due to improved cerebral oxygen delivery.

Hypothesis II: C-UCM and cerebral regional oxygen saturation (crSO2) Infants with C-UCM have higher crSO2 values during immediate neonatal transition, compared to infants without C-UCM, again due to improved cerebral oxygen delivery.

Hypothesis III: C-UCM and stroke volume (SV) In infants with C-UCM the SV at 15 minutes after birth is higher, compared to infants without C-UCM

Hypothesis IV: C-UCM and cardiac output (CO) In infants with C-UCM the CO at 15 minutes after birth is higher, compared to infants without C-UCM.

Hypothesis V: C-UCM and mean arterial blood pressure (MABP) In infants with C-UCM the MABP at 5, 10 and 15 minutes after birth is higher, compared to infants without C-UCM.

Study population

Preterm infants Neonates with a gestational age ≥28 - 37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.

Term Infants Neonates with a gestational age ≥37 weeks delivered by caesarean section at the Department of Obstetrics and Gynaecology, Medical University of Graz, will be enrolled into the study, provided written informed consent is obtained from parents prior to birth. Neonates with severe congenital malformations will be excluded.

Study design

The present study is designed as a randomized controlled pilot trial. As there have not been prior human studies investigating C-UCM regarding the outcome measures cerebral oxygenation and perfusion, a randomized controlled pilot study is the appropriate first step to be able to calculate sample size for a bigger trial.

Sample Size

Sample size calculations were not performed, since there are no data from previous human studies available, and this pilot study needs to be conducted to generate data for the sample size calculation of a consecutive main study. For this pilot study a sample size of 80 infants (20 subjects in the intervention group of preterm infants, 20 subjects in the intervention group of term infants, 20 subjects in each of the two control groups) is arbitrary designated.

Procedure

The medical history focussing on any pathologic findings during pregnancy and delivery will be collected and stored anonymously.

After delivery of the neonate via caesarean section, in the intervention group the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team. In contrast, in the control group the umbilical cord is cut according to the standard procedure and no C-UCM is performed. The further treatment procedure is the same in both groups.

A NIRS transducer will be placed on the newborn's left forehead, and fixed with a modified neonatal CPAP cap or gauze bandage by a scientific staff member without disturbing routine medical care. Furthermore, a pulse oximeter sensor will be attached on the right wrist or palm to monitor preductal oxygen saturation by pulse oximetry (SpO2) and heart rate (HR). Moreover 4 electrodes are fixed on the skin for the non-invasive cardiac output monitoring (NICOM) to evaluate SV and CO. All the measurements will be performed within the first 15 minutes after birth.

Intervention The pneumatic cuff for the oscillometric measurements of the arterial blood pressure will be placed around the left upper arm (or alternatively on the left lower leg) at 5, 10 and 15 minutes after birth. A capillary blood gas check 15 minutes after birth will be performed in all the patients; However infants in need for respiratory support during postnatal stabilisation receive this blood gas check routinely. Moreover, rectal temperature will be measured at 15 minutes after birth.

A stopwatch is started at delivery, the time points of umbilical cord clamping, C-UCM in the intervention group, establishment of NIRS measurement, establishment of SpO2 measurement, and blood drawing for the gas check will be noted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Infant Term Infant Transition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

Milking the cut umbilical cord once towards the Infant at a speed of 10cm/second.

Group Type EXPERIMENTAL

Intervention Group

Intervention Type OTHER

After delivery of the neonate via caesarean section the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team.

Control Group

The umbilical cord is cut according to the standard procedure and no C-UCM is performed.

Group Type ACTIVE_COMPARATOR

Control Group

Intervention Type OTHER

The umbilical cord is cut according to the standard procedure and no C-UCM is performed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Group

After delivery of the neonate via caesarean section the umbilical cord will be clamped within 30 seconds and cut long at least 30 cm by the obstetrician. The neonate is then placed under an overhead heater by the midwife. There, the umbilical cord must be untwisted and held in a vertical position. It is milked once by the neonatologist towards the baby at a speed of approximately 10 cm/s and then clamped 3 cm from the umbilicus by one member of the clinical team.

Intervention Type OTHER

Control Group

The umbilical cord is cut according to the standard procedure and no C-UCM is performed.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cut umbilical cord milking (C-UCM) Standard care

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neonates with a gestational age ≥28 weeks
* Delivered by caesarean section
* Decision to conduct full life support
* Written informed consent prior to birth

Exclusion Criteria

* Neonates with a gestational age \<28 weeks
* No decision to conduct full life support
* No written informed consent
* Severe congenital malformations
Minimum Eligible Age

1 Minute

Maximum Eligible Age

15 Minutes

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Graz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Berndt Urlesberger, Professor

Role: PRINCIPAL_INVESTIGATOR

Division of Neonatology, Medical University of Graz

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dep. of Pediatrics, Medical University of Graz

Graz, Styria, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1223-3280

Identifier Type: OTHER

Identifier Source: secondary_id

30-450 ex 17/18

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.